Microbiotica
PrivateLast Round
Series B
Mar 7, 2022
Est. Valuation
$118.5M
Total Funding Raised
$77.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Microbiotica is a biotechnology company that develops live bacterial therapeutics and biomarkers based on microbiome science.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Microbiotica Comparables
Compare Microbiotica with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EnteroBiotix | 87% | |
| Exeliom Biosciences | 84% | |
| MRM Health | 83% |
Microbiotica Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 7, 2022 | ||||
| VC Round | Oct 24, 2018 | ||||
| Seed | Dec 19, 2016 |
Key People
Founding team and executive leadership
Microbiotica Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IP Group | Series B, Seed |
| Flerie Invest | Series B |
| British Patient Capital | Series B |
| British Patient Capital | Series B |
| Cambridge Innovation Capital | Series B, Seed |
| Flerie AB | Series B |
| Seventure Partners | Series B, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 24, 2026
Monthly visitors increased 55% MoM.
- May 12, 2026
Monthly visitors grew 101% MoM.
Microbiotica Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Microbiotica's valuation, stock price, and market status.
Is Microbiotica a public or private company?
Microbiotica is a private company.
What is the current stock price of Microbiotica?
Microbiotica is a private company with no public stock price. No recent secondary market data is available.
How much is Microbiotica worth (valuation)?
Valuation information for Microbiotica is not publicly available.
Can I buy Microbiotica stock?
Microbiotica shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Microbiotica's last funding round?
Microbiotica's most recent funding round was Series B on March 7, 2022.
Who are the main investors in Microbiotica?
Key investors in Microbiotica include IP Group, Flerie Invest, Cambridge Innovation Capital, Seventure Partners.
Will Microbiotica IPO soon?
No public IPO plans have been announced for Microbiotica.
How can I track Microbiotica secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Microbiotica's secondary market activity and sign up for updates.